Replimune Group, Inc.
REPL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $850 | $785 | $1,011 |
| - Cash | $102 | $97 | $111 | $172 |
| + Debt | $72 | $76 | $76 | $76 |
| Enterprise Value | – | $829 | $751 | $915 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$1 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$82 | -$89 | -$72 | -$65 |
| % Margin | – | – | – | – |
| Net Income | -$83 | -$87 | -$74 | -$66 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.9 | -0.95 | -0.96 | -0.79 |
| % Growth | 5.3% | 1% | -21.5% | – |
| Operating Cash Flow | -$81 | -$77 | -$54 | -$51 |
| Capital Expenditures | -$1 | -$3 | -$1 | -$2 |
| Free Cash Flow | -$83 | -$80 | -$55 | -$53 |